首页> 外国专利> Urinary sediment and / or urine mRNA ratio that is a prognostic marker and / or a terranostic marker for prostate cancer

Urinary sediment and / or urine mRNA ratio that is a prognostic marker and / or a terranostic marker for prostate cancer

机译:尿沉渣和/或尿液mRNA比值是前列腺癌的预后标志和/或地形学标志

摘要

Described herein are methods and kits for prognosis of prostate cancer in a subject. The methods comprises: (a) determining the ratio of PCA3 and PSA expression in a urine sample and (b) correlating the value of the PCA3/PSA ratio with the aggressiveness and mortality risk of prostate cancer in the subject. Kits for prognosing prostate cancer are also described. More particularly, the present invention features a method for prognosing prostate cancer in a biological sample of a patient comprising: assessing the amount of a prostate cancer specific PCA3 mRNA and the amount of PSA in the biological sample; determining a ratio value of this amount of prostate cancer specific PCA3 mRNA over the amount of PSA; comparing the ratio value to at least one predetermined cut-off value, wherein a ratio value above the predetermined cut-off value is indicative of a higher risk of mortality of prostate cancer as compared to a ratio value below the predetermined cut-off value.
机译:本文描述了用于在受试者中预后前列腺癌的方法和试剂盒。该方法包括:(a)确定尿液样品中PCA3和PSA表达的比率,以及(b)将PCA3 / PSA比率的值与受试者中前列腺癌的侵袭性和死亡风险相关联。还描述了用于预测前列腺癌的试剂盒。更具体地,本发明的特征在于一种用于在患者的生物样品中预后前列腺癌的方法,该方法包括:评估该生物样品中前列腺癌特异性PCA3 mRNA的量和PSA的量;以及确定该前列腺癌特异性PCA3 mRNA的量与PSA的量的比值;将比率值与至少一个预定的临界值进行比较,其中比预定的临界值高的比率值表示与低于预定的临界值的比率值相比更高的前列腺癌死亡风险。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号